Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 218,141,489 papers from all fields of science
Search
Sign In
Create Free Account
CYP2A6 gene
Known as:
Cytochrome P450, Family 2, Subfamily A, Polypeptide 6 Gene
, CPA6
, cytochrome P450 family 2 subfamily A member 6
Expand
This gene plays a role in the oxidation of nicotine to its carcinogenic metabolites.
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
10 relations
CYP2A13 gene
CYP2A7 gene
CYP2B6 gene
Carcinogen Metabolism
Expand
Narrower (1)
CYP2A6 wt Allele
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2012
Highly Cited
2012
Genetic variation in CYP2A6 predicts neural reactivity to smoking cues as measured using fMRI
D. Tang
,
B. Hello
,
M. Mroziewicz
,
L. Fellows
,
R. Tyndale
,
A. Dagher
NeuroImage
2012
Corpus ID: 8287420
Highly Cited
2006
Highly Cited
2006
Impact of CYP2A6 genotype on pretreatment smoking behaviour and nicotine levels from and usage of nicotine replacement therapy
V. Malaiyandi
,
C. Lerman
,
N. Benowitz
,
C. Jepson
,
F. Patterson
,
R. Tyndale
Molecular Psychiatry
2006
Corpus ID: 39167880
We investigated the effect of slow metabolism of nicotine, predicted by CYP2A6 genotypes resulting in ⩽50% activity, on baseline…
Expand
Highly Cited
2006
Highly Cited
2006
CYP2A6 Genotype, Phenotype, and the Use of Nicotine Metabolites as Biomarkers during Ad libitum Smoking
V. Malaiyandi
,
Shari D Goodz
,
E. Sellers
,
R. Tyndale
Cancer Epidemiology, Biomarkers and Prevention
2006
Corpus ID: 20503855
CYP2A6 inactivates nicotine to cotinine and cotinine to 3-hydroxycotinine. We investigated which of plasma nicotine and…
Expand
Review
2005
Review
2005
Implications of CYP2A6 Genetic Variation for Smoking Behaviors and Nicotine Dependence
V. Malaiyandi
,
E. Sellers
,
R. Tyndale
Clinical pharmacology and therapy
2005
Corpus ID: 23948245
Highly Cited
2005
Highly Cited
2005
Nicotine metabolism: the impact of CYP2A6 on estimates of additive genetic influence
G. Swan
,
N. Benowitz
,
C. N. Lessov
,
P. Jacob
,
R. Tyndale
,
K. Wilhelmsen
Pharmacogenetics & Genomics
2005
Corpus ID: 24323256
To conduct a pharmacogenetic investigation of nicotine metabolism in twins. One hundred and thirty nine twin pairs [110…
Expand
Highly Cited
2004
Highly Cited
2004
Ethnic variation in CYP2A6 and association of genetically slow nicotine metabolism and smoking in adult Caucasians.
K. Schoedel
,
E. Hoffmann
,
Yushu Rao
,
E. Sellers
,
R. Tyndale
Pharmacogenetics (London)
2004
Corpus ID: 10917310
Genetically variable CYP2A6 is the primary enzyme that inactivates nicotine to cotinine. Our objective was to investigate allele…
Expand
Highly Cited
2003
Highly Cited
2003
Down-regulation of hepatic nicotine metabolism and a CYP2A6-like enzyme in African green monkeys after long-term nicotine administration.
K. Schoedel
,
E. Sellers
,
R. Palmour
,
R. Tyndale
Molecular Pharmacology
2003
Corpus ID: 20567330
Nicotine metabolism is decreased in smokers compared with nonsmokers, but the mechanism(s) responsible for the slower metabolism…
Expand
Highly Cited
2001
Highly Cited
2001
Nicotine metabolism and CYP2A6 allele frequencies in Koreans.
J. Kwon
,
M. Nakajima
,
+7 authors
T. Yokoi
Pharmacogenetics (London)
2001
Corpus ID: 11158162
CYP2A6 is a major catalyst of nicotine metabolism to cotinine. Previously, we demonstrated that the interindividual difference in…
Expand
Highly Cited
1999
Highly Cited
1999
Roles of CYP2A6 and CYP2B6 in nicotine C-oxidation by human liver microsomes
H. Yamazaki
,
Kiyoshi Inoue
,
M. Hashimoto
,
T. Shimada
Archives of Toxicology
1999
Corpus ID: 28436350
Abstract Nicotine C-oxidation by recombinant human cytochrome P450 (P450 or CYP) enzymes and by human liver microsomes was…
Expand
Highly Cited
1990
Highly Cited
1990
Identification of the human liver cytochrome P-450 responsible for coumarin 7-hydroxylase activity.
J. S. Miles
,
A. McLaren
,
L. Forrester
,
M. J. Glancey
,
M. Lang
,
C. Wolf
Biochemical Journal
1990
Corpus ID: 36103492
1. We have constructed a full-length human liver cytochrome P450IIA cDNA from a partial-length clone by oligonucleotide-directed…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE